Literature DB >> 3821730

Adenovirus origin of DNA replication: sequence requirements for replication in vitro.

R J Wides, M D Challberg, D R Rawlins, T J Kelly.   

Abstract

The initiation of adenovirus DNA takes place at the termini of the viral genome and requires the presence of specific nucleotide sequence elements. To define the sequence organization of the viral origin, we tested a large number of deletion, insertion, and base substitution mutants for their ability to support initiation and replication in vitro. The data demonstrate that the origin consists of at least three functionally distinct domains, A, B, and C. Domain A (nucleotides 1 to 18) contains the minimal sequence sufficient for origin function. Domains B (nucleotides 19 to 40) and C (nucleotides 41 to 51) contain accessory sequences that significantly increase the activity of the minimal origin. The presence of domain B increases the efficiency of initiation by more than 10-fold in vitro, and the presence of domains B and C increases the efficiency of initiation by more than 30-fold. Mutations that alter the distance between the minimal origin and the accessory domains by one or two base pairs dramatically decrease initiation efficiency. This critical spacing requirement suggests that there are specific interactions between the factors that recognize the two regions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3821730      PMCID: PMC365145          DOI: 10.1128/mcb.7.2.864-874.1987

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  48 in total

1.  Adenovirus DNA replication in vitro: origin and direction of daughter strand synthesis.

Authors:  M D Challberg; T J Kelly
Journal:  J Mol Biol       Date:  1979-12-25       Impact factor: 5.469

2.  Local mutagenesis: a method for generating viral mutants with base substitutions in preselected regions of the viral genome.

Authors:  D Shortle; D Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

3.  Studies on the mechanism of replication of adenovirus DNA. III. Electron microscopy of replicating DNA.

Authors:  D J Ellens; J S Sussenbach; H S Jansz
Journal:  Virology       Date:  1974-10       Impact factor: 3.616

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  The nucleotide sequences at the termini of adenovirus-2 DNA.

Authors:  J R Arrand; R J Roberts
Journal:  J Mol Biol       Date:  1979-03-15       Impact factor: 5.469

6.  Adenovirus DNA replication in vitro: characterization of a protein covalently linked to nascent DNA strands.

Authors:  M D Challberg; S V Desiderio; T J Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

7.  The structure of replicating adenovirus 2 DNA molecules.

Authors:  R L Lechner; T J Kelly
Journal:  Cell       Date:  1977-12       Impact factor: 41.582

8.  Adenovirus DNA replication in vitro.

Authors:  M D Challberg; T J Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

9.  Identification of the gene and mRNA for the adenovirus terminal protein precursor.

Authors:  B W Stillman; J B Lewis; L T Chow; M B Mathews; J E Smart
Journal:  Cell       Date:  1981-02       Impact factor: 41.582

10.  Sequence-specific interactions between cellular DNA-binding proteins and the adenovirus origin of DNA replication.

Authors:  P J Rosenfeld; E A O'Neill; R J Wides; T J Kelly
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

View more
  37 in total

1.  Improved production of gutted adenovirus in cells expressing adenovirus preterminal protein and DNA polymerase.

Authors:  D Hartigan-O'Connor; A Amalfitano; J S Chamberlain
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  Transcription factors NFI and NFIII/oct-1 function independently, employing different mechanisms to enhance adenovirus DNA replication.

Authors:  Y M Mul; C P Verrijzer; P C van der Vliet
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

Review 3.  Recognition mechanisms in the synthesis of animal virus DNA.

Authors:  R T Hay; W C Russell
Journal:  Biochem J       Date:  1989-02-15       Impact factor: 3.857

4.  Nuclear factor I is specifically targeted to discrete subnuclear sites in adenovirus type 2-infected cells.

Authors:  J Bosher; A Dawson; R T Hay
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

5.  Adenovirus E4 34k and E1b 55k oncoproteins target host DNA ligase IV for proteasomal degradation.

Authors:  Amy Baker; Kent J Rohleder; Les A Hanakahi; Gary Ketner
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

6.  Elements in the transcriptional regulatory region flanking herpes simplex virus type 1 oriS stimulate origin function.

Authors:  S W Wong; P A Schaffer
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

7.  Analysis of multiple forms of nuclear factor I in human and murine cell lines.

Authors:  N Goyal; J Knox; R M Gronostajski
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

8.  NFI and Oct-1 bend the Ad5 origin in the same direction leading to optimal DNA replication.

Authors:  Monika E Mysiak; Claire Wyman; P Elly Holthuizen; Peter C van der Vliet
Journal:  Nucleic Acids Res       Date:  2004-12-01       Impact factor: 16.971

9.  Physical interaction of tumour suppressor p53/p73 with CCAAT-binding transcription factor 2 (CTF2) and differential regulation of human high-mobility group 1 (HMG1) gene expression.

Authors:  Hidetaka Uramoto; Hiroto Izumi; Gunji Nagatani; Haruki Ohmori; Naofumi Nagasue; Tomoko Ise; Takeshi Yoshida; Kosei Yasumoto; Kimitoshi Kohno
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

10.  Mutations in two cysteine-histidine-rich clusters in adenovirus type 2 DNA polymerase affect DNA binding.

Authors:  I Joung; J A Engler
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.